FWP - Cassava Sciences NRx Pharmaceuticals Innate Pharma among major healthcare premarket losers' pack
Jaguar Health (NASDAQ:JAGX) -21% slumps 10% on 1-for-3 reverse stock split announcement. Forward Pharma (NASDAQ:FWP) -17% after Technical Board of Appeal of the European Patent Office has dismissed Forward’s appeal of the previous decision of the EPO Opposition Division to revoke the EP2801355 patent. Innate Pharma (NASDAQ:IPHA) -15%. Evolv Technologies (NASDAQ:EVLV) -12%. NRx Pharmaceuticals (NASDAQ:NRXP) -8%. Cellect Biotechnology (NASDAQ:APOP) -7%. Cassava Sciences (NASDAQ:SAVA) -6%. ADMA Biologics (NASDAQ:ADMA) -5% on distribution pact with Raymond James & Associates
For further details see:
Cassava Sciences, NRx Pharmaceuticals, Innate Pharma among major healthcare premarket losers' pack